MoneyWeek

City talk

● I had planned to nominate my “business villains of 2023”, but the “list of rogues and cheats and chancers is a rich seam” (see page 27) and space is limited, says Patrick Hosking in The Times. So let’s cheer some, the new boss at Rolls-Royce, who arrived promising a more disciplined approach to capital and costs, and to “stamp hard” on the urge to build market share at the expense of profits. Twelve months on, the shares have tripled. Another “champion of shareholder value” is, the CEO of 3i, the most successful UK investment trust this year. His “gigantic bet” on Action, a retail chain, paid off 100-fold. , the CEO of Novo Nordisk, has seen his firm become the biggest in Europe on the back of its potential blockbuster obesity drugs. Finally,, the “hands-on” chairman of M&S, “deserves kudos” for turning the chain around. The shares doubled in a year and are paying dividends again.

You’re reading a preview, subscribe to read more.

More from MoneyWeek

MoneyWeek2 min read
A Work Of Art On Wheels
“Don’t think of the Aston Martin DB12 Volante as the softer, squishier option,” says Alan Taylor-Jones for Car magazine, because the drop-top is every bit the equal of the hard-top DB12 coupe that was launched last year. They were developed side by s
MoneyWeek4 min read
Should You Sell In May This Year?
There is a rule of thumb in the City that you should buy a share if it goes up on bad news and sell one if it goes down on good news. The reason for this is that the share price tells you very quickly whether the good or bad news is already discounte
MoneyWeek2 min read
A Mid Cap Maintaining Momentum
Chemring is a FTSE-250 company with a market value of £943m. Its results for the year to 31 October 2023 were released last December. They revealed the largest order book for over a decade, revenue of £473m (up by 19%), underlying operating profit of

Related Books & Audiobooks